首页> 美国卫生研究院文献>other >Indication for hypertrophy posterior longitudinal ligament removal in anterior decompression for cervical spondylotic myelopathy
【2h】

Indication for hypertrophy posterior longitudinal ligament removal in anterior decompression for cervical spondylotic myelopathy

机译:颈椎病脊髓前路减压术中肥大后纵韧带去除的适应症

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The retrospective study aimed to investigate the indication for hypertrophy posterior longitudinal ligament (HPLL) removal in anterior decompression for cervical spondylotic myelopathy (CSM). A total of 138 consecutive patients with CSM were divided into 2 groups with developmental cervical stenosis (DCS) (group S) and non-DCS (group N), according to the Pavlov ratio. These 2 groups were subdivided into 2 further subgroups, according to whether HPLL was removed or preserved: group SR (49 patients) and group SP (32 patients) in group S, group NR (21 patients) and group NP (36 patients) in group N. The modified Japanese Orthopedic Association score (mJOA), the modified recovery rate (mRR), quality of life (QoL), and relevant clinical data were used for clinical and radiological evaluation. The mJOA scores improved from 7.3 ± 2.2 to 15.0 ± 1.8 in the SR group and from 7.9 ± 2.3 to 14.2 ± 1.5 in the SP group (P = .036), with postoperative QoL significantly higher in the SR group than the SP group. A reduction in the diameter of enlarged spinal canals occurred at a significantly faster rate in the SP group compared with the SR group (P = .002). Multivariate regression analyses showed removal of HPLL correlated with mJOA scores (coefficient = 7.337, P = .002), mRR (%) (coefficient = 9.117, P = .005), PCS (coefficient = 12.129, P < .001), and MCS (coefficient = 14.31, P < .001) in the S group at 24 months postoperatively, while removal of HPLL did not correlate with clinical outcomes in the N group. The HPLL should, therefore, be removed when mobility was reduced and the spinal cord remained compressed after anterior decompression procedures in the patients with DCS. However, in non-DCS patients, it remains unclear as to whether removal of HPLL provides any clinical benefit, thus, HPLL removal may not be necessary.
机译:这项回顾性研究旨在探讨颈椎病型脊髓病(CSM)前减压中肥厚性后纵韧带(HPLL)去除的适应症。根据帕夫洛夫比率,将总共138例连续的CSM患者分为发展性颈椎狭窄(DCS)(S组)和非DCS(N组)的两组。根据是否去除或保留HPLL,将这两组分为亚组:SR组(49例)和SP组(32例),S组,NR组(21例)和NP组(36例)。 N组。修改后的日本骨科协会评分(mJOA),修改后的恢复率(mRR),生活质量(QoL)和相关的临床数据用于临床和放射学评估。 SR组mJOA评分从7.3±2.2提高到15.0 to±1.8,SP组从7.9±2.3提高到14.2±1.5(P = .036),SR组术后QoL显着高于SP组。与SR组相比,SP组的椎管增大直径减小的速度明显快(P = .002)。多元回归分析显示,与mJOA分数(系数=(7.337,P = .002),mRR(%)(系数= 9.117,P = .005),PCS(系数= 12.129,P <.001)相关的HPLL的去除术后24个月,S组的MCS(系数= 14.31,P <.001),而N组的HPLL的去除与临床结果无关。因此,DCS患者在进行前减压手术后,其活动性降低且脊髓保持受压状态时,应去除HPLL。但是,在非DCS患者中,是否去除HPLL是否可提供任何临床益处尚不清楚,因此,可能不需要去除HPLL。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号